ArticleSurgical endoscopy2026
Comparison of minimally invasive single-position left transthoracic and esophageal hiatal approach versus laparoscopic transesophageal hiatus approach for Siewert type II adenocarcinoma of the esophagogastric junction.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo explore the validity and feasibility of a minimally invasive single-position left transthoracic and esophageal hiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction.
methodsClinical data of 196 patients with Siewert type II AEG treated by the same surgical team from January 2017 to December 2019 at our institution were retrospectively analyzed. Patients were categorized into the minimally invasive single-position left transthoracic and esophageal hiatal approach (SLTEA) group (n = 106) and the minimally invasive laparoscopic transesophageal hiatus approach (LTHA) group (n = 90) according to the surgical approach, and the clinical data, perioperative indices, and postoperative survival rates of the two groups were compared.
resultsThe SLTEA group had shorter surgical time, first ambulation time after surgery, first postoperative intestinal peristalsis time, and postoperative hospital stay than the LTHA group (P < 0.001). Besides, the SLTEA group had longer proximal esophageal cut edge length and a higher total number of lymph node dissections than the LTHA group (P < 0.001). The K-M survival curve shows that the five-year overall survival rate of the SLTEA group is higher than that of the LTHA group (P = 0.0386).
conclusionFor patients with Siewert type II AEG, the minimally invasive SLTEA is safe and effective, with shorter operative time, longer esophageal margins, more complete lymph node dissection, better postoperative recovery, and more benefits for patients' long-term survival. It can be promoted as a complementary option to Siewert type II AEG surgery.
Indexed as
Identifiers
42310199What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.